West Pharmaceutical Services Inc(WST)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

WST West Pharmaceutical Services Inc

休市中 02-13 16:00:00 EST

250.49

+6.88

+2.82%

盘后250.49

+0.000.00%

19:37 EST

最高250.53	最低242.14	成交量98.03万
今开243.94	昨收243.61	日振幅3.44%
总市值180.21亿	流通市值178.88亿	总股本7,194万
成交额2.43亿	换手率1.37%	流通股本7,141万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"WST","market":"US","secType":"STK","nameCN":"West Pharmaceutical Services Inc","latestPrice":250.49,"timestamp":1771016400000,"preClose":243.61,"halted":0,"volume":980268,"hourTrading":{"tag":"盘后","latestPrice":250.49,"preClose":250.49,"latestTime":"19:37 EST","volume":33860,"amount":8482422.39,"timestamp":1771029435751,"change":0,"changeRate":0,"amplitude":0.006747},"delay":0,"changeRate":0.02824186199252902,"floatShares":71412408,"shares":71943412,"eps":6.751478,"marketStatus":"休市中","change":6.88,"latestTime":"02-13 16:00:00 EST","open":243.94,"high":250.53,"low":242.14,"amount":243449744.05092,"amplitude":0.03444,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.751478,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":391752000000,"exchange":"NYSE","adjPreClose":243.61,"dividendRate":0.003353,"preHourTrading":{"tag":"盘前","latestPrice":238.42,"preClose":243.61,"latestTime":"09:27 EST","volume":6,"amount":1440.9,"timestamp":1770992820757,"change":-5.19,"changeRate":-0.021305,"amplitude":0.021305},"postHourTrading":{"tag":"盘后","latestPrice":250.49,"preClose":250.49,"latestTime":"19:37 EST","volume":33860,"amount":8482422.39,"timestamp":1771029435751,"change":0,"changeRate":0,"amplitude":0.006747},"volumeRatio":0.6505428949599633,"impliedVol":0.403,"impliedVolPercentile":0.5936},"requestUrl":"/m/hq/s/WST/tweets","defaultTab":"tweets","newsList":[{"id":"1186611264","title":"异动解读 | 西氏医药盘中大跌5.02%，市场担忧GLP-1药物需求增速放缓","url":"https://stock-news.laohu8.com/highlight/detail?id=1186611264","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186611264?lang=zh_cn&edition=full","pubTime":"2026-02-13 01:22","pubTimestamp":1770916931,"startTime":"0","endTime":"0","summary":"西氏医药服务公司今日盘中股价大跌5.02%，引起了市场关注。消息面上，公司虽然预测2026年调整后每股利润将高于华尔街预期，但其高管在电话会议中指出，用于糖尿病和肥胖症治疗的GLP-1类药物需求在2026年的增长节奏将比2025年“放缓”。尽管公司第四季度业绩及年度利润指引均超出预期，但市场焦点似乎转向了对主力产品需求增速可能见顶以及长期增长门槛较高的疑虑上。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WST"],"gpt_icon":0},{"id":"1189264003","title":"西氏医药高管：GLP-1药物采用率需超30%方能实现公司10%同比增速","url":"https://stock-news.laohu8.com/highlight/detail?id=1189264003","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189264003?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:39","pubTimestamp":1770903556,"startTime":"0","endTime":"0","summary":"在最新电话会议中，西氏医药服务公司高管指出，若要推动公司年同比增长率达到10%，GLP-1类药物的市场渗透率必须突破30%的关键阈值。这一表态凸显了新型代谢疗法对医疗供应链企业的业绩拉动作用，也反映出制药行业技术变革对上下游产业的深远影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0012050646.USD","LU0345774391.USD","IE00B64QTZ34.USD","IE00BFXG0V08.USD","BK4588","BK4585","BK4567","LU0106261612.USD","BK4504","WST","IE00BYQQ9H92.USD","BK4121","LU0345774631.USD"],"gpt_icon":0},{"id":"1132302810","title":"West Pharma高管称客户行为未现变化 年度预测为保守起点-电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1132302810","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132302810?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:36","pubTimestamp":1770903388,"startTime":"0","endTime":"0","summary":"在最新电话会议中，West Pharmaceutical Services Inc高管表示，目前未观察到客户行为出现显著变化。公司将其年度财务预测描述为\"保守的起点\"，强调这一规划基于当前市场环境的审慎评估。管理层指出，尽管全球经济存在不确定性，但主营业务需求保持稳定，对实现全年目标持谨慎乐观态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261612.USD","WST","IE00BYQQ9H92.USD","BK4588","LU0012050646.USD","IE00B64QTZ34.USD","LU0345774631.USD","BK4585","BK4567","LU0345774391.USD","BK4504","BK4121","IE00BFXG0V08.USD"],"gpt_icon":0},{"id":"1149286797","title":"West Pharma高管：GLP-1需求预计2026年继续增长，但增速将低于2025年","url":"https://stock-news.laohu8.com/highlight/detail?id=1149286797","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149286797?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:26","pubTimestamp":1770902776,"startTime":"0","endTime":"0","summary":"在最新电话会议中，West Pharmaceutical Services Inc高管指出，尽管GLP-1类药物需求在2025年呈现强劲增势，但预计2026年增长节奏将有所放缓。该预测反映了市场对这类代谢疾病治疗药物长期需求曲线的专业判断，同时暗示行业可能进入阶段性调整期。值得注意的是，增速回落并非需求萎缩，而是市场基数扩大后的自然演化，全球糖尿病与肥胖症治疗领域的底层需求依然坚实。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0012050646.USD","IE00B64QTZ34.USD","BK4121","LU0345774391.USD","BK4504","BK4585","WST","IE00BYQQ9H92.USD","LU0106261612.USD","IE00BFXG0V08.USD","LU0345774631.USD","BK4588","BK4567"],"gpt_icon":0},{"id":"1146290440","title":"West Pharma高管重申：预计2026年GLP-1注射与口服剂型将持续增长——电话会议透露","url":"https://stock-news.laohu8.com/highlight/detail?id=1146290440","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146290440?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:17","pubTimestamp":1770902235,"startTime":"0","endTime":"0","summary":"在最新电话会议中，West Pharmaceutical高管明确表示，公司对2026年GLP-1类药物市场前景保持乐观。无论是注射剂型还是口服剂型，均被预期为驱动业务增长的双引擎。这一表态凸显了企业对该细分领域长期需求的信心，同时也反映出制药行业技术路线多元化的趋势正在加速渗透。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4567","LU0012050646.USD","IE00BFXG0V08.USD","LU0345774631.USD","BK4504","IE00BYQQ9H92.USD","BK4588","WST","IE00B64QTZ34.USD","LU0345774391.USD","LU0106261612.USD","BK4121"],"gpt_icon":0},{"id":"1162396907","title":"West Pharma高管预计2026年将呈现\"广泛增长态势\"，非GLP-1高价值部件驱动中低个位数增长——电话会议实录","url":"https://stock-news.laohu8.com/highlight/detail?id=1162396907","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162396907?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:13","pubTimestamp":1770901997,"startTime":"0","endTime":"0","summary":"在最新电话会议中，West Pharmaceutical高管层透露，公司对2026年业绩展望持乐观态度，预计将形成\"全面增长格局\"。这一增长动能主要来源于非GLP-1高价值产品组合的持续发力，其增速预计将维持在中等至较低个位数区间。值得注意的是，管理层特别强调非GLP-1业务线的稳健性。虽然当前市场焦点集中于GLP-1相关领域，但公司传统高价值部件展现出的韧性将成为未来增长的重要支柱。通过精准的产品组合策略与技术创新，West Pharmaceutical正逐步构建跨越不同医疗领域的增长引擎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","IE00BFXG0V08.USD","LU0012050646.USD","LU0345774391.USD","IE00B64QTZ34.USD","LU0106261612.USD","LU0345774631.USD","BK4121","WST","BK4585","IE00BYQQ9H92.USD","BK4588","BK4567"],"gpt_icon":0},{"id":"2603796764","title":"2026斯诺克世界大奖赛携全新赛制即将香港开赛","url":"https://stock-news.laohu8.com/highlight/detail?id=2603796764","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603796764?lang=zh_cn&edition=full","pubTime":"2026-01-16 18:49","pubTimestamp":1768560540,"startTime":"0","endTime":"0","summary":"今年2月，斯诺克世界的目光将再度聚焦东方之珠。2026年2月3日至8日，世界斯诺克巡回赛排名赛——斯诺克世界大奖赛2026将在中国香港启德体育园回归。令人振奋的是，中国选手在本赛季表现强势，共有10人成功锁定席位，刷新该赛事中国军团参赛人数纪录。为了提升赛事的公平性与观赏性，2026年世界大奖赛赛制迎来重要革新，赛事落户香港后，比赛影响力不断上涨。敬请关注“2026斯诺克世界大奖赛”官方赛事信息，获取最新动态与购票信息。","market":"hk","thumbnail":"https://media.bjnews.com.cn/image/2026/01/16/5676284735010185713.png?x-oss-process=image/resize,m_lfit,w_365","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/image/2026/01/16/5676284735010185713.png?x-oss-process=image/resize,m_lfit,w_365"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1768555955129573.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1768555955129573.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["WST","IE00BYQQ9H92.USD","LU0345774391.USD","BK4588","BK4585","LU0012050646.USD","BK4504","BK4121","LU0345774631.USD","IE00BFXG0V08.USD","IE00B64QTZ34.USD","LU0106261612.USD","BK4567"],"gpt_icon":0},{"id":"1140361953","title":"艾伯维收购亚利桑那州生产设施，持续强化美国本土制造能力","url":"https://stock-news.laohu8.com/highlight/detail?id=1140361953","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140361953?lang=zh_cn&edition=full","pubTime":"2026-01-12 19:01","pubTimestamp":1768215713,"startTime":"0","endTime":"0","summary":"艾伯维公司近日宣布，将收购位于亚利桑那州的一处生产设施。这一战略举措旨在进一步增强其在美国本土的制造实力，为未来的产品供应提供有力保障。收购完成后，该设施将整合进艾伯维现有的生产网络，提升其在关键治疗领域的产能与灵活性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015952.SGD","LU0124676726.USD","LU0289739699.SGD","SG9999011175.SGD","LU1037948897.HKD","LU0211328371.USD","LU1983299246.USD","LU2129689605.HKD","LU0965509010.AUD","LU2237443895.HKD","LU1732799900.SGD","IE00BYQQ9H92.USD","LU0689472784.USD","LU0795875169.SGD","LU1074936037.SGD","LU1291159041.SGD","IE00B42XCP33.USD","SG9999001440.SGD","LU0545039389.USD","IE00B4R5TH58.HKD","IE00BLSP4239.USD","SG9999015986.USD","BK4121","LU0456855351.SGD","LU0256863811.USD","LU1934455863.HKD","LU1496350171.SGD","LU0820561909.HKD","LU2129689514.USD","BK4533","LU0820561818.USD","IE00BLSP4452.SGD","LU2089283258.USD","LU1989772840.SGD","LU0949170772.SGD","LU0170899867.USD","LU1057294990.SGD","LU1496350502.SGD","LU1989771016.USD","LU0310800379.SGD","IE00BFTCPJ56.SGD","IE00BGHQF631.EUR","IE0009355771.USD","LU0098860793.USD","LU0114720955.EUR","LU0708994859.HKD","IE0004445239.USD","LU1430594728.SGD","IE00BVYPNV92.GBP","LU2129689431.USD","LU0661504455.SGD","LU1162221912.USD","LU2237443622.USD","LU2089284900.SGD","BK4559","LU0882574055.USD","LU1718418525.SGD","LU2087621335.USD","LU0320765646.SGD","IE00B3PB1722.GBP","LU2089984988.USD","LU1267930573.SGD","IE00B2B36J28.USD","LU1244550221.USD","LU0943347566.SGD","IE00BSNM7G36.USD","LU1585245621.USD","LU2347655156.SGD","LU1244550494.USD","LU2237443465.HKD","LU2023251221.USD","LU0912757837.SGD","SG9999003800.SGD","IE00B19Z3B42.SGD","LU2237443978.SGD","LU0553294199.USD","LU1839511570.USD","BK4585","LU0417517546.SGD","WST","IE0002270589.USD","BK4567","LU0106261612.USD","LU2112291526.USD","LU1061106388.HKD","LU1989772923.USD","BK4504","ABBV","LU0256863902.USD","LU1551013342.USD","LU0965508806.USD","LU0012050646.USD","LU0345774631.USD","BK4534","BK4139","IE00BBT3K403.USD","LU0198837287.USD","LU0795875086.SGD","IE00B64QTZ34.USD","LU0234570918.USD","BK4588","LU1267930490.SGD","IE0002141913.USD","IE00BN8TJ469.HKD","LU0432979614.USD","LU0158827948.USD","LU2237443549.SGD","LU0203347892.USD","LU0985320562.USD","LU1929549753.HKD","LU1551013425.SGD","LU1037948541.HKD","IE00BVYPNW00.USD","LU0965509283.SGD","BK4550","LU1934455277.USD","LU1732800096.USD","LU1023059063.AUD","LU0203345920.USD","BK4566","LU2468319806.SGD","LU0128525929.USD","LU1093756325.SGD","LU1934455194.USD","BK4581","LU1003077747.HKD","LU1093756168.USD","LU0122379950.USD","LU0965509101.SGD","LU0029864427.USD","LU0861579265.USD","LU0738911758.USD","LU0058720904.USD","LU0689626769.HKD","LU0211327993.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","SG9999015978.USD","LU2237443382.USD","LU0310799852.SGD","IE00BFXG0V08.USD","LU0345774391.USD","LU1244550577.SGD","SG9999015945.SGD","LU2133065610.SGD","IE00BDGV0183.EUR","LU0234572021.USD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"1179506181","title":"异动解读 | 西方制药服务股价盘中大涨9.41%，业绩超预期且上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1179506181","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179506181?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:34","pubTimestamp":1761226474,"startTime":"0","endTime":"0","summary":"西方制药服务今日盘中股价大涨9.41%，引发市场广泛关注。这一显著涨幅主要源于公司发布的强劲第三季度财报结果和乐观的未来展望。更值得注意的是，西方制药服务大幅上调了2025年全年业绩指引。公司预计2025年调整后每股收益将达到7.06美元至7.11美元之间，显著高于此前预期的6.65美元至6.85美元。西方制药服务的核心优势在于其药物元件业务，该业务占公司总收入的47%。随着这些药物需求的持续增长，西方制药服务有望继续受益于这一趋势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WST"],"gpt_icon":1},{"id":"1194419731","title":"异动解读 | West Pharmaceutical Services盘前大涨6.50%，第三季度业绩超预期并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1194419731","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194419731?lang=zh_cn&edition=full","pubTime":"2025-10-23 19:06","pubTimestamp":1761217602,"startTime":"0","endTime":"0","summary":"医疗设备制造商West Pharmaceutical Services今日盘前大涨6.50%，引发市场广泛关注。根据公司最新发布的财报，West Pharmaceutical第三季度业绩表现出色，大幅超出市场预期。更值得注意的是，West Pharmaceutical大幅上调了2025年全年业绩指引。West Pharmaceutical的核心优势在于其药物元件业务，该业务占公司总收入的47%。随着这些药物需求的持续增长，West Pharmaceutical有望继续受益于这一趋势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WST"],"gpt_icon":1},{"id":"1163375042","title":"更正：West Pharmaceutical上调全年调整后每股收益指导范围，从6.65美元提升至6.85美元（而非“全年每股收益6.65-6.85美元”）","url":"https://stock-news.laohu8.com/highlight/detail?id=1163375042","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163375042?lang=zh_cn&edition=full","pubTime":"2025-10-23 18:49","pubTimestamp":1761216540,"startTime":"0","endTime":"0","summary":"更正：West Pharmaceutical上调全年调整后每股收益指导范围，从6.65美元提升至6.85美元（而非“全年每股收益6.65-6.85美元”）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","IE00B64QTZ34.USD","BK4567","IE00BFXG0V08.USD","WST","BK4504","BK4585","BK4588","IE00BYQQ9H92.USD"],"gpt_icon":0},{"id":"1122490882","title":"West Pharmaceutical Services Inc：预计2025年第四季度调整后摊薄每股收益指导范围为1.81至1.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122490882","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122490882?lang=zh_cn&edition=full","pubTime":"2025-10-23 18:03","pubTimestamp":1761213797,"startTime":"0","endTime":"0","summary":"West Pharmaceutical Services Inc：预计2025年第四季度调整后摊薄每股收益指导范围为1.81至1.86美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","WST","BK4588","IE00B64QTZ34.USD","BK4121","IE00BFXG0V08.USD","BK4567","BK4504","IE00BYQQ9H92.USD"],"gpt_icon":0},{"id":"1190007722","title":"西方制药服务：2025年第四季度财务指引预测净销售增长将达5.5%至6.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1190007722","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190007722?lang=zh_cn&edition=full","pubTime":"2025-10-23 18:03","pubTimestamp":1761213792,"startTime":"0","endTime":"0","summary":"西方制药服务：2025年第四季度财务指引预测净销售增长将达5.5%至6.8%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64QTZ34.USD","IE00BYQQ9H92.USD","BK4585","WST","BK4588","BK4504","BK4121","IE00BFXG0V08.USD","BK4567"],"gpt_icon":0},{"id":"1169871485","title":"West Pharmaceutical Services Inc：预计2025年第四季度净销售指导区间为7.9亿到8亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169871485","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169871485?lang=zh_cn&edition=full","pubTime":"2025-10-23 18:02","pubTimestamp":1761213779,"startTime":"0","endTime":"0","summary":"West Pharmaceutical Services Inc：预计2025年第四季度净销售指导区间为7.9亿到8亿美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","IE00B64QTZ34.USD","IE00BFXG0V08.USD","IE00BYQQ9H92.USD","BK4585","BK4504","BK4567","WST","BK4588"],"gpt_icon":0},{"id":"1113034171","title":"一周美股牛股 | 伊瑞保险、Fair Isaac涨超11%；West Pharmaceutical涨10%；Solventum涨9%；财捷涨8%；美国电塔涨7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113034171","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113034171?lang=zh_cn&edition=full","pubTime":"2025-03-03 10:37","pubTimestamp":1740969431,"startTime":"0","endTime":"0","summary":"上周伊瑞保险股价上涨11.6%。伊瑞保险表示，其保单签发与续期服务的管理费收入在2024年同比增长4.52亿美元，第四季度同比增加9670万美元。$Fair Isaac Corp$  Q1业绩强劲，股价飙升11%上上周，Fair Isaac宣布与与肯尼亚 TransUnion 合作推出新的信用风险解决方案，以提升金融普惠性。加之公司近期更新股票回购计划并给出乐观财年指引，投资者热情高涨，推动其股价上周上涨11.09%。","market":"us","thumbnail":"https://community-static.tradeup.com/news/fd176bd3635d0bbb104ba2e21f7080af","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/fd176bd3635d0bbb104ba2e21f7080af"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b3c3776ec6b9c6be559d2d5aef531479","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"一周美股牛股 | 伊瑞保险、Fair Isaac涨超11%；West Pharmaceutical涨10%；Solventum涨9%；财捷涨8%；美...","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMT","RTX","SOLV","WST","ERIE","CINF","TRV","FICO","INTU","AIG"],"gpt_icon":1},{"id":"2511133286","title":"Keybanc：维持West Pharmaceutical Servs(WST.US)评级，由增持调整至增持评级, 目标价由470.00美元调整至325.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511133286","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511133286?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:33","pubTimestamp":1739554413,"startTime":"0","endTime":"0","summary":"Keybanc：维持West Pharmaceutical Servs(WST.US)评级，由增持调整至增持评级, 目标价由470.00美元调整至325.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/15013348179357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["WST"],"gpt_icon":0},{"id":"2511699532","title":"West Pharmaceutical Services, Inc.涨3.62% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2511699532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511699532?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:33","pubTimestamp":1739543595,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时33分，West Pharmaceutical Services, Inc.股票出现异动，股价大幅拉升3.62%。West Pharmaceutical Services, Inc.股票所在的医疗设备行业中，整体涨幅为0.36%。其相关个股中，West Pharmaceutical Services, Inc.、Staar Surgical Company、Azenta, Inc.涨幅较大，Avinger, Inc.、Sharps Technology Inc.、Microbot Medical Inc.较为活跃，换手率分别为13.57%、1.69%、1.51%，振幅较大的相关个股有Ekso Bionics Holdings, Inc.、Avinger, Inc.、Stevanato Group S.P.A.，振幅分别为5.59%、5.02%、3.10%。West Pharmaceutical Services, Inc.公司简介：西氏医药服务总部位于美国宾夕法尼亚州，是一家制药、生物技术和仿制药行业公司的主要供应商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223315a2460165&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223315a2460165&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IE00BYQQ9H92.USD","IE00B64QTZ34.USD","BK4567","BK4504","BK4585","WST","IE00BFXG0V08.USD","BK4121"],"gpt_icon":0},{"id":"1159151157","title":"异动解读 | 西药公司2025年业绩预期大跌,股价盘中暴跌23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159151157","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159151157?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:39","pubTimestamp":1739457562,"startTime":"0","endTime":"0","summary":"西药公司今日盘中股价大跌23.14%,引发市场广泛关注。公司公布的2025年业绩预期大幅低于市场预期,成为导致股价暴跌的主因。西药公司解释称,业绩预期不佳主要是受到美元走强以及生物科技客户去库存行为的影响。疫情期间,西药公司的生物技术客户曾因供应链中断而大量囤积库存,但现在需求下降令公司业绩承压。此外,专有产品业务去年第四季度同比增长放缓,也对全年业绩造成一定冲击。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WST"],"gpt_icon":0},{"id":"2511526638","title":"West Pharmaceutical Services, Inc.盘中异动 急速下挫23.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511526638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511526638?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:33","pubTimestamp":1739457186,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时33分，West Pharmaceutical Services, Inc.股票出现异动，股价快速跳水23.98%。West Pharmaceutical Services, Inc.股票所在的医疗设备行业中，整体跌幅为0.52%。其相关个股中，Avinger, Inc.、Predictive Oncology Inc.、中进医疗涨幅较大，Avinger, Inc.、Sharps Technology Inc.、Glucotrack, Inc.较为活跃，换手率分别为351.90%、8.96%、1.41%，振幅较大的相关个股有Avinger, Inc.、Sharps Technology Inc.、AtriCure，振幅分别为8.89%、6.70%、6.28%。West Pharmaceutical Services, Inc.公司简介：西氏医药服务总部位于美国宾夕法尼亚州，是一家制药、生物技术和仿制药行业公司的主要供应商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223306a244aba1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223306a244aba1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4504","BK4567","IE00BFXG0V08.USD","BK4121","BK4585","WST","IE00BYQQ9H92.USD","IE00B64QTZ34.USD","BK4588"],"gpt_icon":0},{"id":"1149588111","title":"异动解读 | 西药公司业绩预期大失所望,股价暴跌近20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149588111","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149588111?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:20","pubTimestamp":1739456423,"startTime":"0","endTime":"0","summary":"在本周四的盘前交易中,西药公司(WST)的股价暴跌了19.95%,引发了市场的广泛关注。\n\n根据公司发布的信息,导致股价大跌的主要原因是公司公布的2025年业绩预期大幅低于市场预期。公司预计全年收入在28.8亿到29.1亿美元之间,中位值低于分析师预期的30.4亿美元;同时全年每股盈利预期在6美元到6.2美元之间,也远低于预期的7.44美元。\n\n公司解释称,业绩预期不佳的原因主要是美元走强,以及客户继续在去库存的影响。据悉,在新冠疫情期间,西药公司的生物科技客户曾大量囤积库存,导致近期需求下滑,对公司业绩造成了一定的压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 西药公司业绩预期大失所望,股价暴跌近20%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WST"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.westpharma.com","stockEarnings":[{"period":"1week","weight":0.0062},{"period":"1month","weight":-0.0891},{"period":"3month","weight":-0.0416},{"period":"6month","weight":0.0174},{"period":"1year","weight":0.258},{"period":"ytd","weight":-0.0896}],"compareEarnings":[{"period":"1week","weight":-0.0128},{"period":"1month","weight":-0.0125},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.0595},{"period":"1year","weight":0.1181},{"period":"ytd","weight":-0.0002}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"West Pharmaceutical Services, Inc.根据宾夕法尼亚州的法律于1923年7月27日成立。该公司是设计和生产技术先进，高质量，集成化的用于注射药物和保健产品的密封和输送系统的全球领先制造商。该公司的产品包括各种初级包装，容纳解决方案，重构和转移系统，药物输送系统，以及合同制造，分析实验室服务和集成解决方案。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.008018},{"month":2,"riseRate":0.543478,"avgChangeRate":0.002779},{"month":3,"riseRate":0.6,"avgChangeRate":0.022464},{"month":4,"riseRate":0.586957,"avgChangeRate":0.037291},{"month":5,"riseRate":0.543478,"avgChangeRate":0.001622},{"month":6,"riseRate":0.565217,"avgChangeRate":0.017803},{"month":7,"riseRate":0.586957,"avgChangeRate":0.011963},{"month":8,"riseRate":0.608696,"avgChangeRate":0.008395},{"month":9,"riseRate":0.478261,"avgChangeRate":-0.00228},{"month":10,"riseRate":0.565217,"avgChangeRate":0.005454},{"month":11,"riseRate":0.695652,"avgChangeRate":0.016909},{"month":12,"riseRate":0.673913,"avgChangeRate":0.026146}],"exchange":"NYSE","name":"West Pharmaceutical Services Inc","nameEN":"West Pharmaceutical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"West Pharmaceutical Services Inc(WST)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供West Pharmaceutical Services Inc(WST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"West Pharmaceutical Services Inc,WST,West Pharmaceutical Services Inc股票,West Pharmaceutical Services Inc股票老虎,West Pharmaceutical Services Inc股票老虎国际,West Pharmaceutical Services Inc行情,West Pharmaceutical Services Inc股票行情,West Pharmaceutical Services Inc股价,West Pharmaceutical Services Inc股市,West Pharmaceutical Services Inc股票价格,West Pharmaceutical Services Inc股票交易,West Pharmaceutical Services Inc股票购买,West Pharmaceutical Services Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"West Pharmaceutical Services Inc(WST)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供West Pharmaceutical Services Inc(WST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}